An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

about

Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis.

P2860

Q55347709-084D8A16-13C0-4295-8D21-EC8AEAB8777E

P2860

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

Item

http://www.wikidata.org/entity/Q51730313

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@en

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@nl

type

Item

label

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@en

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@nl

prefLabel

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@en

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@nl

P1476

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

@en

P2093

Andrew P Herbert

http://www.w3.org/2001/XMLSchema#string

Harriet Denton

http://www.w3.org/2001/XMLSchema#string

Heather Kerr

http://www.w3.org/2001/XMLSchema#string

Kate Smith-Jackson

http://www.w3.org/2001/XMLSchema#string

Matthew C Pickering

http://www.w3.org/2001/XMLSchema#string

Paul N Barlow

http://www.w3.org/2001/XMLSchema#string

Yi Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH)

Molecular cloning of a human serum protein structurally related to complement factor H

Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.

Control of the amplification convertase of complement by the plasma protein beta1H

Structural basis for engagement by complement factor H of C3b on a self surface

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases

Eculizumab for dense deposit disease and C3 glomerulonephritis

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Structure of complement fragment C3b-factor H and implications for host protection by complement regulators

P31

scholarly article

P356

10.1681/ASN.2017091006

http://www.w3.org/2001/XMLSchema#string

P50

Kevin J Marchbank

Owen R Davies

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29588430

http://www.w3.org/2001/XMLSchema#string

P932

6054357

http://www.w3.org/2001/XMLSchema#string

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

about

P2860

P2860

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P932